Returning for its 7th year, IMPACCT: Real World Evidence provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to suppo
Use of real-world evidence is becoming increasingly common to aid the clinical development process and provide important data for pricing discussions once medicines have been approved.
Pharma companies need to rethink how they communicate and share information and insights within their own organisations, according to Syneos Health’s principal for real world and late phase
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.